Veterinary Medicines

Clavucill 400 mg + 100 mg 400 mg - 100 mg Tablet

Authorised
  • POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)
  • Amoxicillin trihydrate
Download as PDF

Product identification

Medicine name:
Clavucill 400mg/100mg Tabletten für Hunde
Clavucill 400 mg + 100 mg 400 mg - 100 mg Tablet
Active substance:
  • POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)
  • Amoxicillin trihydrate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)
    250.20
    milligram(s)
    /
    1.00
    Tablet
  • Amoxicillin trihydrate
    459.10
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • Clavucill 400 mg + 100 mg 400 mg - 100 mg tabl. 100
  • Clavucill 400 mg + 100 mg 400 mg - 100 mg tabl. 10

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • VMD N.V.
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 401560.02.00
Date of authorisation status change:
Reference member state:
  • Belgium
Procedure number:
  • BE/V/0024/003
Concerned member states:
  • Denmark
  • France
  • Germany
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Spain
  • Sweden
Generic of:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 13/01/2025
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 13/01/2025
Download